Abstract:Abstract Atopic dermatitis (AD) is a common, relapsing–remitting inflammatory skin disease that is associated with other disorders such as food allergy, allergic asthma and rhinitis, leading to increased rates of morbidity and mortality. The discovery of CD1a involvement in AD pathogenesis through the presentation of permissive neolipid antigens generated by house dust mite phospholipase A2 (PLA2) enhanced our understanding of the complex network of T-cell targets that contribute to disease development. As well as defining agonist lipids, it is now known that very long-chain sphingomyelins can act as natural lipid antagonists of CD1a–T-cell receptor (TCR) engagement. We sought to determine whether bacterial sphingomyelinases (SMases) could also activate CD1a-reactive T cells and help explain the known bacterial infection-associated manifestations of AD. An isoelectric focusing system was used to evaluate the hydrolytic capacity of bacterial SMases on very long-chain CD1a-preferred sphingomyelins. Additionally, this approach permitted examination of the impact of cobalt and nickel ions on bacterial SMase activity. Furthermore, using primary human T-cell clones and TCR transfer with CRISPR Homology Directed Repair, we evaluated SMase-reactive CD1a-dependent T-cell responses. Moreover, we examined both lesional and nonlesional skin from patients with AD, patients with psoriasis and healthy controls using RNA-Seq. Bacterial SMases were able to digest CD1a-selected sphingomyelins, and the enzymatic activity was potentiated by the presence of divalent metal ions, which are known contact dermatitis allergens. Furthermore, bacterial SMase-reactive CD1a-dependent T-cell responses were identified through markedly increased detection of AD-associated inflammatory cytokines and elevated activation marker expression. Consistency of responses between the primary T-cell clones and HDR T cells confirmed that these responses were indeed TCR specific. Skin transcriptomic changes included altered lipid processing pathways, in particular, mammalian SMase and PLA2-mediated pathways, activated in lesional tissue. We showed that bacterial SMases can effectively degrade very long-chain antagonist sphingomyelins and potentiate CD1a-reactive T-cell responses. In addition, our bioinformatics analysis revealed enhanced expression of mammalian SMases in lesional AD and psoriasis, suggesting potential broad involvement of this enzyme class in skin inflammation. This study extends our understanding of the role of lipid-metabolizing enzymes to CD1a-dependent T-cell activation in AD pathology, as well as defining a hitherto unknown pathway of contact dermatitis. The mechanisms provide insights towards novel targets for therapeutic intervention. The principal investigator has received relevant research collaboration support from UCB and Janssen. The principal investigator and some members of the group are on patents filed on CD1a.

CD1a and skin T cells – a pathway for therapeutic intervention

CD1a on Langerhans cells controls inflammatory skin diseases.

Exploring Mast Cell-CD8 T Cell Interactions in Inflammatory Skin Diseases

Characterization of human skin-derived CD1a-positive lymph cells

CD15 The role of lipid-metabolizing enzymes in CD1a-associated cutaneous inflammation

CD1-mediated immune responses in mucosal tissues: molecular mechanisms underlying lipid antigen presentation system

CD1 molecules: Beyond antigen presentation

CD1: A Singed Cat of the Three Antigen Presentation Systems

CD1 Expression on Antigen-Presenting Cells

CD1d-restricted T cell pathways at the epithelial-lymphocyte-luminal interface

CCL27–CCR10 interactions regulate T cell–mediated skin inflammation

Human autoreactive T cells recognize CD1b and phospholipids

The Role of Langerhans Cells in Epidermal Homeostasis and Pathogenesis of Psoriasis

Langerhans cells and skin immune diseases

Langerhans cell: exciting developments in health and disease

T cell pathology in skin inflammation

Exploring the Common Pathogenic Mechanisms of Psoriasis and Atopic Dermatitis: the Interaction Between SGK1 and TIGIT Signaling Pathways

UVB-induced skin inflammation and cutaneous tissue injury is dependent on the MHC class I-like protein, CD1d

T-Cell Adhesion in Healthy and Inflamed Skin

T cells promote distinct transcriptional programs of cutaneous inflammatory disease in keratinocytes and dermal fibroblasts

Expression of CD1d in human scalp skin and hair follicles: hair cycle related alterations